腎亮細胞癌與非亮腎細胞癌之診斷率與其治療預後隨時間演進之發展-台中榮民總醫院經驗
邱俊凱、楊晨洸1
台中榮民總醫院 外科部 泌尿科；1台中榮民總醫院醫院 外科部 泌尿科
New development of diagnosis and prognosis for Renal Clear cell carcinoma and non- clear cell carcinoma – VGTCH experience
Chiou JK1, Yang CK2,
1Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan,2 Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan,
Purpose: As the progress in department of pathology nowadays, we can now have more accurate pathology diagnosis for non-clear cell carcinoma and its subtypes. We analyze these data for general populations, treatment outcomes, long term survival, recurrence rates.
Materials and Methods: We retrospectively collect a total 307 Renal cell carcinoma patients who received either radical or partial nephrectomy at our hospital for past 2 decades. We analyze the total proportional of non-clear cell carcinoma and its subtypes comparing to worldwide literature. Prognosis and treatment option was also analyze in different period of time.
Results: We found 51 patient about 16% of our patient group pathology report as non-clear cell carcinoma and 80% of the case was diagnosed in recent 5 years. There is significant difference in diagnosis rate, prognosis and survival benefit in differed period of time. But no statically difference in type of surgery and whether partial or radical nephrectomy.
Conclusions: Progress in pathology department had influence our treatment strategy and decision making. We can now even track back some rapid progression and poor outcome patient to understand the etiology. We need more Taiwan database to create a better and through research.